Olesen, Jes
Funding for this research was provided by:
Copenhagen University
Article History
Received: 30 October 2024
Accepted: 30 October 2024
First Online: 19 December 2024
Declarations
:
: JO owns stock in Novo, Lundbeck, Moberg Pharma and Cephagenix.